AIHW logo

METEOR logo

Our sites
AIHW GEN Aged Care Data Aboriginal and Torres Strait Islander
Health Performance Framework
Indigenous Mental Health and
Suicide Prevention Clearinghouse
Australian Mesothelioma Registry Housing data Regional Insights for Indigenous Communities
Contact FAQs

Site Navigation

  • Find metadata
    • Find metadata
    • Getting started
    • Data set specifications
    • Indicator sets
    • Data quality statements
    • Data dictionary archives
  • Metadata management
    • Metadata management
    • Data standards
    • Registration authorities
    • Registration statuses
  • How to use METEOR
    • How to use METEOR
    • First steps
    • Using My Page
    • Downloading and printing
    • FAQs
    • About METEOR
  • Learn about metadata
    • Learn about metadata
    • Metadata explained
    • How to create metadata
    • Metadata development resources
Your session is about to end!
Your session will expire at [TIME]
Select Extend at the top right corner or you will be logged out

Person—diabetes therapy type, code NN

Data Element Attributes

Identifying and definitional attributes

Metadata item type:Help on this termData Element
Short name:Help on this termDiabetes therapy type
METEOR identifier:Help on this term270236
Registration status:Help on this term

Health, Standard 01/03/2005

Definition:Help on this termThe type of diabetes therapy the person is currently receiving, as represented by a code.
Data Element Concept:Help on this termPerson—diabetes therapy type
Value Domain:Help on this termDiabetes therapy code NN

Value domain attributes

Representational attributes

Representation class:Help on this termCode
Data type:Help on this termString
Format:Help on this termNN
Maximum character length:Help on this term2
  ValueMeaning
Permissible values:Help on this term01Diet and exercise only
  02Oral hypoglycaemic - sulphonylurea only
  03Oral hypoglycaemic - biguanide (eg metformin) only
  04Oral hypoglycaemic - alpha-glucosidase inhibitor only
  05Oral hypoglycaemic - thiazolidinedione only
  06Oral hypoglycaemic - meglitinide only
  07Oral hypoglycaemic - combination (eg biguanide & sulphonylurea)
  08Oral hypoglycaemic - other
  09 Insulin only
  10Insulin plus oral hypoglycaemic
  98Nil - not currently receiving diabetes treatment
Supplementary values:Help on this term99
 
Not stated/inadequately described
 

Collection and usage attributes

Guide for use:Help on this term

CODE 01     Diet & exercise only

This code includes the options of generalised prescribed diet; avoid added sugar/simple carbohydrates (CHOs); low joule diet; portion exchange diet and uses glycaemic index and a recommendation for increased exercise.

CODE 98     Nil - not currently receiving diabetes treatment

This code is used when there is no current diet, tablets or insulin therapy(ies).

CODE 99     Not stated/inadequately described

Use this code when missing information.

Data element attributes Help on this term

Collection and usage attributes

Collection methods:Help on this termTo be collected at the commencement of treatment and at each review.
Comments:Help on this term

In settings where the monitoring of a person's health is ongoing and where management can change over time (such as general practice), the Service contact—service contact date, DDMMYYYY should be recorded.

The main use of this data element is to enable categorisation of management regimes against best practice for diabetes.

Source and reference attributes

Submitting organisation:Help on this term

National Diabetes Data Working Group

Cardiovascular Data Working Group

Reference documents:Help on this termBerkow R, editor. The Merck Manual. 16th ed. Rahway (New Jersey, USA): Merck Research Laboratories; 1992.

Relational attributes

Related metadata references:Help on this term
Is re-engineered from PDF Diabetes therapy type, version 1, DE, NHDD, NHIMG, Superseded 01/03/2005.pdf (19.1 KB)

        No registration status

See also Female—type of diabetes mellitus therapy during pregnancy, code N

        Health, Superseded 09/09/2022

See also Female—type of diabetes mellitus therapy during pregnancy, code N

        Health, Superseded 20/11/2019

See also Female—type of diabetes mellitus therapy during pregnancy, code N

        Health, Superseded 02/08/2017

See also Female—type of diabetes mellitus therapy during pregnancy, code N

        Health, Superseded 12/12/2018

See also Female—type of diabetes mellitus therapy during pregnancy, code N

        Health, Standard 09/09/2022

Implementation in Data Set Specifications:Help on this term
All attributes +
Acute coronary syndrome (clinical) DSS

        Health, Superseded 01/09/2012


Acute coronary syndrome (clinical) DSS

        Health, Superseded 02/05/2013


Acute coronary syndrome (clinical) NBPDS 2013-

        Health, Standard 02/05/2013

DSS specific attributes +
Implementation start date: 01/07/2013

Cardiovascular disease (clinical) DSS

        Health, Superseded 15/02/2006


Cardiovascular disease (clinical) DSS

        Health, Superseded 04/07/2007


Cardiovascular disease (clinical) DSS

        Health, Superseded 22/12/2009


Cardiovascular disease (clinical) DSS

        Health, Superseded 01/09/2012


Cardiovascular disease (clinical) NBPDS

        Health, Superseded 17/10/2018


Cardiovascular disease (clinical) NBPDS

        Health, Standard 17/10/2018


Diabetes (clinical) DSS

        Health, Superseded 21/09/2005

DSS specific attributes +
DSS specific information:

The objectives and priorities of treatment must be tailored to the individual considering age, sex, weight and individual health status.

An individual management plan for each patient should include the following:

  • establishment of targets of treatment
  • healthy eating plan
  • education in self-monitoring,
  • adjustment of treatment and in approaches to coping with emergencies
  • exercise program
  • risk factor reduction, e.g. smoking cessation
  • use of oral hypoglycaemic agents, if required
  • use of insulin, if required
  • screening for and treatment of complications of diabetes.

In addition to glycaemic control, management of diabetes of either type requires close attention to other risk factors for the development of complications, and the impact of lifestyle changes on blood glucose levels should be monitored. In patients with Type 2 diabetes, an increase in physical activity is essential in management of lipids and glucose level. Increased physical activity has been recognised as perhaps the most feasible way of modifying glucose intolerance, a risk factor for developing diabetes and macrovascular disease (Guest & O'Dea 1992).


Diabetes (clinical) NBPDS

        Health, Standard 21/09/2005

DSS specific attributes +
DSS specific information:

The objectives and priorities of treatment must be tailored to the individual considering age, sex, weight and individual health status.

An individual management plan for each patient should include the following:

  • establishment of targets of treatment
  • healthy eating plan
  • education in self-monitoring,
  • adjustment of treatment and in approaches to coping with emergencies
  • exercise program
  • risk factor reduction, e.g. smoking cessation
  • use of oral hypoglycaemic agents, if required
  • use of insulin, if required
  • screening for and treatment of complications of diabetes.

In addition to glycaemic control, management of diabetes of either type requires close attention to other risk factors for the development of complications, and the impact of lifestyle changes on blood glucose levels should be monitored. In patients with Type 2 diabetes, an increase in physical activity is essential in management of lipids and glucose level. Increased physical activity has been recognised as perhaps the most feasible way of modifying glucose intolerance, a risk factor for developing diabetes and macrovascular disease (Guest & O'Dea 1992).


<Title>

<body>
<footer>

View

  • Show more
  • Print view

Download

  • Word
  • PDF
  • Advanced options

Review

  • Compare items
Help
Downloading

The download may take a while, please wait.

Do not refresh the screen until the download is complete.

Terms & Conditions
Do you agree with the Terms and Conditions?

<Title>

<body>
<footer>
Loading...

Navigation

  • Find metadata
  • Metadata management
  • How to use METEOR
  • Learn about metadata

Resources

  • Accessibility
  • Copyright
  • Disclaimer
  • Freedom of Information
  • Privacy policy
  • Vulnerability and disclosure policy

Quick Links

  • Contact
  • FAQs
  • Search
AIHW logo
© Australian Insitute of Health and Welfware, 2023